선택지 정리됨
Vulvar / vaginal cancer: 국가별 선택지
이 페이지는 한국어 임상 치료 설명을 새로 쓰지 않습니다. 권위 출처, 진료 전 정리 질문, 임상시험 검색어, 구축 상태를 보여주는 안전한 시작점입니다.
선택지 정리됨고형암최종 확인 2026.06
현재 제공
국가별 선택지를 정리합니다
국가별로 출처가 연결된 선택지와 함께, 진단명·단계·검사 결과·진료과·임상시험 검색어를 정리합니다.
아직 하지 않음
치료 선택을 지시하지 않습니다
이 페이지는 치료 순위, 권장, 적합성 판단을 하지 않습니다.
출처
공신력 있는 출처 기반
모든 선택지는 규제·평가·지침 등 공신력 있는 출처에 연결되며, 새 출처가 검증되면 계속 확장됩니다.
진료 전 정리할 정보
- 이 항목은 원문 출처와 함께 의료진에게 확인하세요.
- 이 항목은 원문 출처와 함께 의료진에게 확인하세요.
- 이 항목은 원문 출처와 함께 의료진에게 확인하세요.
- 이 항목은 원문 출처와 함께 의료진에게 확인하세요.
임상시험 검색어
국가별 선택지
국가별 치료 선택지
공식 규제·평가 기관 출처를 바탕으로 한 국가별 승인·접근 상태입니다. 무엇이 어디에 존재하는지를 보여줄 뿐, 추천이 아닙니다.
United Kingdom
- Vulval cancer: surgery, radiotherapy, chemotherapy, palliative/symptom-control care. Vaginal cancer: radiotherapy including brachytherapy, surgery in selected settings, chemotherapy with radiotherapy, and follow-up care.[1]Standard option (per NHS)Vulval cancer general treatment including early, before/after surgery, non-surgical, spread/symptom-control contexts; vaginal cancer general treatment including radiotherapy main treatment, early surgery, post-radiotherapy failure, and chemoradiotherapy contexts. · The NHS pages are general treatment information and do not establish drug reimbursement, eligibility, or specialist center access. They do not provide vulvar/vaginal-cancer-specific immunotherapy or targeted-therapy commissioning status. Confidence/conflicts: High for general NHS treatment categories; medium for detailed access because NICE/MHRA and local commissioning were not fetched in this finding.
- Vulval cancer: surgery, radiotherapy, chemotherapy, palliative/symptom-control care. Vaginal cancer: radiotherapy including brachytherapy, surgery in selected settings, chemotherapy with radiotherapy, and follow-up care.[1]Standard option (per NHS)Vulval cancer general treatment including early, before/after surgery, non-surgical, spread/symptom-control contexts; vaginal cancer general treatment including radiotherapy main treatment, early surgery, post-radiotherapy failure, and chemoradiotherapy contexts. · The NHS pages are general treatment information and do not establish drug reimbursement, eligibility, or specialist center access. They do not provide vulvar/vaginal-cancer-specific immunotherapy or targeted-therapy commissioning status. Confidence/conflicts: High for general NHS treatment categories; medium for detailed access because NICE/MHRA and local commissioning were not fetched in this finding.
- Vulval cancer: surgery, radiotherapy, chemotherapy, palliative/symptom-control care. Vaginal cancer: radiotherapy including brachytherapy, surgery in selected settings, chemotherapy with radiotherapy, and follow-up care.[1]Standard option (per NHS)Vulval cancer general treatment including early, before/after surgery, non-surgical, spread/symptom-control contexts; vaginal cancer general treatment including radiotherapy main treatment, early surgery, post-radiotherapy failure, and chemoradiotherapy contexts. · The NHS pages are general treatment information and do not establish drug reimbursement, eligibility, or specialist center access. They do not provide vulvar/vaginal-cancer-specific immunotherapy or targeted-therapy commissioning status. Confidence/conflicts: High for general NHS treatment categories; medium for detailed access because NICE/MHRA and local commissioning were not fetched in this finding.
- Vulval cancer: surgery, radiotherapy, chemotherapy, palliative/symptom-control care. Vaginal cancer: radiotherapy including brachytherapy, surgery in selected settings, chemotherapy with radiotherapy, and follow-up care.[1]Standard option (per NHS)Vulval cancer general treatment including early, before/after surgery, non-surgical, spread/symptom-control contexts; vaginal cancer general treatment including radiotherapy main treatment, early surgery, post-radiotherapy failure, and chemoradiotherapy contexts. · The NHS pages are general treatment information and do not establish drug reimbursement, eligibility, or specialist center access. They do not provide vulvar/vaginal-cancer-specific immunotherapy or targeted-therapy commissioning status. Confidence/conflicts: High for general NHS treatment categories; medium for detailed access because NICE/MHRA and local commissioning were not fetched in this finding.
출처
- NHS — national health-service patient information · national health-service patient information
위 내용은 공식 규제·접근 상태일 뿐, 의학적 조언이나 추천이 아니고, 적격성을 판단하지도 않습니다. 어떤 선택지가 적합한지는 환자의 상황과 종양내과 팀에 달려 있습니다. 규제 상태는 바뀔 수 있으니 표시된 출처에서 확인하세요. 임상 세부 내용은 영문이 정본입니다. 최종 확인 2026-06-12.